Heranba Inds (HERANBA)

Asset Play

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Current Price₹169.76
Market Cap₹679.27 Cr
P/E Ratio0
ROCE4.39%
ROE-9.58%
Dividend Yield0.59%
Profit Growth-57.04%
Debt/Equity0.75
Sales Growth-26.86%
Promoter Holding74.94%
52-Week Range₹155.38 — ₹338
SectorFertilizers & Agrochemicals
Book Value₹190.36

Strengths

Concerns

AI Analysis

At ₹218.15, Heranba is not a wonderful business. It is a distressed agrochemical company trading at ₹0.93 for every ₹1 of book value, with book value at ₹234.69. That sounds like an asset play, and it is. But Graham taught me not to buy assets alone when earnings are deteriorating. Latest quarter: ₹301 Cr revenue and a ₹23 Cr loss. Profit growth is -128.16%, sales growth is -11.70%, and the Piotroski F-Score is only 3/9. These are not the numbers of a company finding its footing. The return on equity is 6.18%, ROCE is just 4.39%, and debt/equity is 0.60. With such low returns, the company is barely covering its cost of capital, and debt makes the risk worse. The promoter holding of 74.94% is a positive: owners have skin in the game. The dividend yield of 0.48% shows some willingness to return cash, but it is small comfort while the company is losing money. The P/E is zero because there is no meaningful profit to capitalise. Valuation can only be tested against assets: ₹234.69 of book value against a price of ₹218.15. That margin is thin, and it can erode if losses continue. This is not a Buffett-style compounder; there is no moat evidence in these numbers. It is a possible asset play with cyclical risk. I would not rush in. I would wait for a few quarters of improving margins, stable or falling debt, and positive operating cash flows. Until I see that, the 0/100 FairStock Score and 3/9 Piotroski score are enough warning to keep my capital disciplined. Price is cheap for a reason.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer